SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001232524-17-000039
Filing Date
2017-03-01
Accepted
2017-03-01 17:18:06
Documents
2
Period of Report
2017-02-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3434
2 EDGAR SUPPORTING DOCUMENT poayoung.txt EX-24 3662
  Complete submission text file 0001232524-17-000039.txt   8629
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 4TH FL.CONNAUGHT HOUSE, 1 BURLINGTON RD. DUBLIN L2 4
Business Address
Young Matthew P. (Reporting) CIK: 0001601583 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 17655515